Publication: MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review)
Open/View Files
Date
2015
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
D.A. Spandidos
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
LI, MING, YING WANG, YONGSHENG SONG, RENGE BU, BO YIN, XIANG FEI, QIZHEN GUO, and BIN WU. 2015. “MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review).” Oncology Reports 33 (4): 1571-1578. doi:10.3892/or.2015.3799. http://dx.doi.org/10.3892/or.2015.3799.
Research Data
Abstract
Despite recent advances in the understanding of the biology of renal cell carcinoma (RCC), successful surgical treatment and implementation of novel-targeted therapies, the prognosis for RCC patients remains poor. Late presentation, tumor heterogeneity and in particular the lack of molecular biomarkers for early detection, classification and the surveillance of RCC treatments are major obstacles. The increasing knowledge regarding the functional role of microRNAs (miRNAs) in pathophysiological processes may provide an important link to the identification of suitable therapeutic targets and diagnostic/prognostic biomarkers for RCC. The aim of this review was to provide new insight into the function of miRNAs in the pathogenesis of RCC and to emphasize their potential as diagnostic and prognostic markers, as well as therapeutic targets.
Description
Other Available Sources
Keywords
renal cell carcinoma, microRNA, diagnosis, prognosis, therapy
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service